Classical risk factors for primary coronary artery disease from an aging perspective through Mendelian Randomization

No abstract is available for this paper.

• Publication year

  2021

• Venue

  GeroScience

• Publication date

  2021-12-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11357-021-00498-9PMID 34932184PMCID PMC9213623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stratification of Type 2 Diabetes by Age of Diagnosis in the UK Biobank Reveals Subgroup-Specific Genetic Associations and Causal Risk Profiles

  2021cited by this paper
• Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.

  2020cited by this paper
• Antihypertensive Agents in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

  2019cited by this paper
• Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines

  2019cited by this paper
• Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.

  2019cited by this paper
• Survival Bias in Mendelian Randomization Studies

  2019cited by this paper
• Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study.

  2019cited by this paper
• Cardiovascular Risk Reduction Associated with Pharmacological Weight Loss: A Meta-Analysis.

  2019cited by this paper
• Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

  2019cited by this paper
• Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

  2018cited by this paper
• Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

  2018cited by this paper
• Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis

  2017cited by this paper
• Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis

  2017cited by this paper
• Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

  2016cited by this paper
• Evidence-based medicine in older patients: how can we do better?

  2015cited by this paper
• The UK10K project identifies rare variants in health and disease

  2015cited by this paper
• The transcriptional landscape of age in human peripheral blood

  2015cited by this paper
• UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

  2015cited by this paper
• A global reference for human genetic variation

  2015cited by this paper
• Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

  2015cited by this paper
• Genetic studies of body mass index yield new insights for obesity biology

  2015influential reference
• Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites.

  2014cited by this paper
• Mendelian randomization of blood lipids for coronary heart disease

  2014cited by this paper
• Discovery and refinement of loci associated with lipid levels

  2013influential reference
• Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease

  2012cited by this paper
• The intersection between aging and cardiovascular disease.

  2012cited by this paper
• glm2: Fitting Generalized Linear Models with Convergence Problems

  2011cited by this paper
• Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk

  2011cited by this paper
• Scikit-learn: Machine Learning in Python

  2011cited by this paper
• Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation

  2011cited by this paper
• Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study

  2010cited by this paper
• The Relationship of DNA Methylation with Age, Gender and Genotype in Twins and Healthy Controls

  2009cited by this paper
• LIBLINEAR: A Library for Large Linear Classification

  2008cited by this paper
• Celebrating the 25 th Anniversary of Statistics in Medicine Mendelian randomization : Using genes as instruments for making causal inferences in epidemiology

  2008cited by this paper
• Treatment of hypertension in patients 80 years of age or older.

  2008cited by this paper
• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

  2007cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002influential reference
• Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group.

  1999cited by this paper
• Blood pressure and risk of myocardial infarction in elderly men and women: the Rotterdam study.

  1999cited by this paper

• Sex-related disparities in coronary artery disease in postmenopausal women-a global view and recommendations for the future.

  2025cites this paper
• Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis

  2024cites this paper
• Overweight as a Causal Factor Contributing to Better Survival at the Oldest Old Ages: A Mendelian Randomization Study

  2024cites this paper
• Large-scale genome-wide interaction analyses on multiple cardiometabolic risk factors to identify age-specific genetic risk factors

  2024cites this paper
• The Application of Mendelian Randomization in Cardiovascular Disease Risk Prediction: Current Status and Future Prospects

  2024cites this paper
• Is being overweight a causal factor in better survival among the oldest old? a Mendelian randomization study

  2024cites this paper
• Mendelian Randomization-Let's Prevent Common Mistakes.

  2024cites this paper
• Association of a composite trait for anthropometrics, adiposity and energy expenditure with cardiometabolic diseases: An age‐stratified cohort and genetic risk score analysis

  2024influential citation
• Role of endocrine PACAP in age-related diseases

  2023cites this paper
• Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank.

  2023cites this paper
• Differential and sex‐ and age‐specific risks of cardiometabolic diseases with unrelated metabolic syndrome dimensions

  2023cites this paper
• Investigating the Association between Coronary Artery Disease and the Liver Fibrosis-4 Index in Patients Who Underwent Coronary Computed Tomography Angiography: A Cross-Sectional Study

  2023cites this paper
• The impact of sociodemographic status on the association of classical cardiovascular risk factors with coronary artery disease: a stratified Mendelian Randomization study.

  2023cites this paper
• Association between systolic blood pressure and low-density lipoprotein cholesterol with coronary heart disease according to age

  2023cites this paper
• The association of measures of body shape and adiposity with incidence of cardiometabolic disease from an ageing perspective

  2022cites this paper